Ubpon, Alaizah Z.
HRN: 28-39-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/06/2026
01/13/2026
IV
415mg
Q6hours
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes